Original ArticlePancreas, Biliary Tract, and LiverSARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
Pancreas, Biliary Tract, and Liver
Keywords
Immunosuppression
Liver Cirrhosis
Liver Transplant Recipients
SARS-CoV-2 Vaccination
Abbreviations used in this paper
Anti-S RBD
anti-SARS-CoV-2 antibodies in Roche Elecsys immunoassay
anti-S trimer
anti-SARS-CoV-2 antibodies in DiaSorin LIAISON immunoassay
BAU
binding antibody units
CI
confidence interval
CNI
calcineurin inhibitor
COVID-19
Coronavirus disease 2019
eGFR
estimated glomerular filtration rate
IGRA
interferon gamma release assay
IFN-γ
interferon-gamma
IQR
interquartile range
LC
liver cirrhosis
LT
liver transplant
MMF
mycophenolate mofetil
mTORi
mammalian target of rapamycin inhibitors
OR
odds ratio
RBD
receptor binding domain
SARS-CoV-2
severe acute respiratory syndrome coronavirus type 2
SD
standard deviation
SOT
solid-organ transplantation
TIPS
transjugular intrahepatic portosystemic stent-shunt
Cited by (0)
Conflicts of interest The authors disclose no conflicts.
Funding Friedrich Haag and Julian Schulze zur Wiesch report research funding from SFB1328, project A12; Golda Meline Schaub was supported by a DZIF MD Stipend through the DZIF academy. Anahita Fahti, Marylyn Martina Addo, and Leonie Mayer report funding from the DZIF TTU 01709. No further funding was used for the research reported.
- a
Authors share co-first authorship.
- b
Authors share co-senior authorship.
© 2022 by the AGA Institute